The University of Tennessee (UT) Board of Trustees has approved a request from the UT Health Science Center (UTHSC) to name the new dental building under construction on the Memphis campus the Delta Dental of Tennessee Building.
Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ensemble trial, according to… Read More
Doctors at University of Tennessee Health Science Center said their COVID-19 treatment study is already off to a better than expected and positive start.Researchers are seeing how well a COVID-19 treatment drug works with the area’s diverse population.
As cases rise across Shelby County there are questions about hospitalization rates and the use of beds in hospitals across the Mid-South. Dr. Jon McCullers, Chairman of the Department of Pediatrics at The University of Tennessee Health Science Center joined WMC Action News 5 Tuesday to talk about the coronavirus pandemic and how it’s impacting… Read More
A local DNA biorepository initiative has grown into one of the largest in the world for children. And now, a partnership with a New York-based pharma firm shows potential in unlocking DNA for research — and, in the future, personalized medicine. In 2015, the University of Tennessee Health Science Center (UTHSC) and Le Bonheur Children’s… Read More
Vietnam veteran Gerry Sandlin had already begun losing his hearing after years of working around helicopters in the 189th Assault Helicopter Company, 52nd Combat Aviation Battalion, but a stroke in 2018 took what was left of his hearing. November 9: Cherokee Tribune & Ledger News
Pfizer announced early Monday, Nov. 9, that its vaccine has shown to be a surprising 90% effective in preventing COVID-19. “The results demonstrate that our mRNA-based vaccine can help prevent COVID-19 in the majority of people who receive it,” Pfizer Chairman and CEO Albert Bourla said. “This means we are one step closer to potentially… Read More
As explained by the National Kidney Foundation, the goal of management of chronic hyperkalemia — i.e., high levels of potassium in the blood — is to prevent the development or recurrence of the condition by correcting the underlying disturbances in potassium balance. However, the use of the term “chronic” may actually be a misnomer in… Read More
